Pediatric developmental epileptic encephalopathies treated with cenobamate: Real-world outcomes across etiologies, syndromes, and seizure types. (PubMed, Epilepsia) - Aug 29, 2026 - "CNB was associated with sustained effectiveness and acceptable tolerability across pediatric DEEs. Slow weight-based titration and proactive simplification of sodium channel blockers and clobazam may optimize benefit-risk."
Journal • Real-world evidence • CNS Disorders • Epilepsy • Pediatrics
|
|
Adrián García-Ron; Adrián Valls-Carbó; Ainhoa García-Ribes; Andrea Sariego Jamardo; Ángel Aledo-Serrano; Antonio Gil-Nagel Rein; David Conejo; Dolors Casellas; Elena González-Alguacil; Elena Miravet; Eulalia Turón Viñas; Eva Arias; Gemma Aznar-Lain; Helena Alarcón Martínez; Irene Sánchez-Miranda Román; Jana Domínguez-Carral; Juan José García-Peñas; Manuel Lorenzo-Diéguez; María Jesús Martínez-González; María López López; María Muñoz Cabeza; Nuria Lamagrande; Patricia Smeyers; Raquel Buenache-Espartosa; Salvador Ibáñez-Micó; Saray Rekarte-García; Susana Boronat; Victor Soto-Insuga; Virginia Navarro
|